McKinney D, Kosnik N, Syed S, Junko G
HCA Healthc J Med. 2025; 6(1):11-21.
PMID: 40071189
PMC: 11892399.
DOI: 10.36518/2689-0216.1802.
Matute D, Teixeira M
PLoS Pathog. 2025; 21(3):e1012898.
PMID: 40048686
PMC: 11884826.
DOI: 10.1371/journal.ppat.1012898.
Saratto T, Visuri K, Lehtinen J, Ortega-Sanz I, Steenwyk J, Sihvonen S
BMC Bioinformatics. 2025; 26(1):12.
PMID: 39806295
PMC: 11731562.
DOI: 10.1186/s12859-024-06005-z.
Krysan D, Jezewski A, Alden K, Daraji D, Lail 3rd C, Propp J
Res Sq. 2025; .
PMID: 39801522
PMC: 11722533.
DOI: 10.21203/rs.3.rs-5619443/v1.
Agyare-Tabbi M, Uthayakumar D, Francis D, Maroc L, Grant C, McQueen P
NPJ Antimicrob Resist. 2024; 2(1):42.
PMID: 39619432
PMC: 11606924.
DOI: 10.1038/s44259-024-00057-0.
Label-Free Optical Transmission Tomography for Direct Mycological Examination and Monitoring of Intracellular Dynamics.
Teston E, Sautour M, Boulnois L, Augey N, Dighab A, Guillet C
J Fungi (Basel). 2024; 10(11).
PMID: 39590661
PMC: 11595662.
DOI: 10.3390/jof10110741.
Antifungal and anti-biofilm effects of hydrazone derivatives on spp.
Popczyk P, Ghinet A, Bortolus C, Kamus L, Lensink M, de Ruyck J
J Enzyme Inhib Med Chem. 2024; 39(1):2429109.
PMID: 39589067
PMC: 11600518.
DOI: 10.1080/14756366.2024.2429109.
Resveratrol-coated gold nanorods produced by green synthesis with activity against .
Fonseca Do Carmo P, Pinheiro Lage A, Garcia M, Da Silva N, Santos D, Mylonakis E
Virulence. 2024; 15(1):2416550.
PMID: 39427236
PMC: 11492707.
DOI: 10.1080/21505594.2024.2416550.
Evolutionary dynamics in gut-colonizing Candida glabrata during caspofungin therapy: Emergence of clinically important mutations in sphingolipid biosynthesis.
Hassoun Y, Aptekmann A, Keniya M, Gomez R, Alayo N, Novi G
PLoS Pathog. 2024; 20(9):e1012521.
PMID: 39250486
PMC: 11412501.
DOI: 10.1371/journal.ppat.1012521.
Strain heterogeneity in a non-pathogenic Aspergillus fungus highlights factors associated with virulence.
Rinker D, Sauters T, Steffen K, Gumilang A, Raja H, Rangel-Grimaldo M
Commun Biol. 2024; 7(1):1082.
PMID: 39232082
PMC: 11374809.
DOI: 10.1038/s42003-024-06756-8.
Brilacidin, a novel antifungal agent against .
Diehl C, Pinzan C, de Castro P, Delbaje E, Garcia Carnero L, Sanchez-Leon E
mBio. 2024; 15(7):e0103124.
PMID: 38916308
PMC: 11253610.
DOI: 10.1128/mbio.01031-24.
Development and Clinical Evaluation of a CRISPR/Cas12a-Based Nucleic Acid Detection Platform for the Diagnosis of Keratomycoses.
Deivarajan H, Elamurugan V, Sivashanmugam P, Pandian J, Sevugamurthi K, Rameshkumar G
Ophthalmol Sci. 2024; 4(5):100522.
PMID: 38881611
PMC: 11179415.
DOI: 10.1016/j.xops.2024.100522.
Design, synthesis and inhibitory activity against Candida albicans of a series of derivatives with 5-nitrofuran scaffold.
Zheng J, Li D, Dong J, Wang P, Geng H
Mol Divers. 2024; .
PMID: 38811449
DOI: 10.1007/s11030-024-10892-y.
Humans vs. Fungi: An Overview of Fungal Pathogens against Humans.
Thambugala K, Daranagama D, Tennakoon D, Jayatunga D, Hongsanan S, Xie N
Pathogens. 2024; 13(5).
PMID: 38787278
PMC: 11124197.
DOI: 10.3390/pathogens13050426.
Strain heterogeneity in a non-pathogenic fungus highlights factors contributing to virulence.
Rinker D, Sauters T, Steffen K, Gumilang A, Raja H, Rangel-Grimaldo M
bioRxiv. 2024; .
PMID: 38496489
PMC: 10942418.
DOI: 10.1101/2024.03.08.583994.
Application of anti-fungal vaccines as a tool against emerging anti-fungal resistance.
Kumar R, Srivastava V
Front Fungal Biol. 2023; 4:1241539.
PMID: 37746132
PMC: 10512234.
DOI: 10.3389/ffunb.2023.1241539.
Application of Exosomes-Derived Mesenchymal Stem Cells in Treatment of Fungal Diseases: From Basic to Clinical Sciences.
Ghasemian S
Front Fungal Biol. 2023; 2:736093.
PMID: 37744094
PMC: 10512299.
DOI: 10.3389/ffunb.2021.736093.
Antifungal activity of protein hydrolysates from Thai Phatthalung Sangyod rice L.) seeds.
Jeenkeawpieam J, Rodjan P, Roytrakul S, Pruksaphon K, Mitsuwan W, Tanthanathipchai N
Vet World. 2023; 16(5):1018-1028.
PMID: 37576760
PMC: 10420720.
DOI: 10.14202/vetworld.2023.1018-1028.
Powering up antifungal treatment: using small molecules to unlock the potential of existing therapies.
Shapiro R, Gerstein A
mBio. 2023; 14(4):e0107323.
PMID: 37530533
PMC: 10470729.
DOI: 10.1128/mbio.01073-23.
Prevalence and predictors of Aspergillus seropositivity and chronic pulmonary aspergillosis in an urban tertiary hospital in Sierra Leone: A cross-sectional study.
Lakoh S, Kamara J, Orefuwa E, Sesay D, Jiba D, Adekanmbi O
PLoS Negl Trop Dis. 2023; 17(7):e0011284.
PMID: 37459359
PMC: 10374077.
DOI: 10.1371/journal.pntd.0011284.